Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s ...

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn’t ...

The College of Natural Sciences welcomed more than a dozen new tenured and tenure-track faculty members in 2024.

Study findings support tivozanib monotherapy for second-line treatment of certain patients with metastatic RCC, an expert ...

Details: Keith Heigel, with Light-Heigel & Associates, who presented the plan, said the expansion would bring about 150 jobs ...

The global dietary supplement market is set for significant growth, projected to reach approximately USD 170.1 billion by ...

(Alliance News) - GSK PLC on Friday announced that it has been granted breakthrough therapy designation in China for Blenrep, a treatment for relapsed or refractory multiple myeloma.